Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1988 2
1989 4
1990 5
1991 5
1992 7
1993 4
1994 5
1995 5
1996 9
1997 2
1998 8
1999 4
2000 3
2001 2
2002 11
2003 6
2004 5
2005 4
2006 3
2007 4
2008 2
2009 3
2010 4
2011 6
2012 2
2013 3
2014 4
2015 7
2016 7
2017 8
2018 3
2019 2
2020 5
2021 10
2022 8
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Nyirjesy P, et al. Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S162-S168. doi: 10.1093/cid/ciab1057. Clin Infect Dis. 2022. PMID: 35416967 Review.
BACKGROUND: Vulvovaginal candidiasis (VVC) is a common cause of vulvovaginal itching and discharge. ...Two new drugs, TOL-463 and recently FDA-approved ibrexafungerp, appeared promising in clinical trials. For recurrent VVC, oteseconazole, not yet comm …
BACKGROUND: Vulvovaginal candidiasis (VVC) is a common cause of vulvovaginal itching and discharge. ...Two new drugs, T …
Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review.
Kalia N, Singh J, Kaur M. Kalia N, et al. Ann Clin Microbiol Antimicrob. 2020 Jan 28;19(1):5. doi: 10.1186/s12941-020-0347-4. Ann Clin Microbiol Antimicrob. 2020. PMID: 31992328 Free PMC article. Review.
Recurrent vulvovaginal infections (RVVI) has not only become an epidemiological and clinical problem but also include large social and psychological consequences. ...Through this review, an attempt has been made to analyze vaginal microbiota (VMB) from scratch and t
Recurrent vulvovaginal infections (RVVI) has not only become an epidemiological and clinical problem but also include large so
Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Gonçalves B, et al. Crit Rev Microbiol. 2016 Nov;42(6):905-27. doi: 10.3109/1040841X.2015.1091805. Epub 2015 Dec 21. Crit Rev Microbiol. 2016. PMID: 26690853 Review.
Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. ...Despite a growing list of recognized risk factors, much remains to be elucidated as the role of host versus microorganisms, in inducing VVC and its
Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. ...Despite
Recurrent vulvovaginal candidiasis.
Sobel JD. Sobel JD. Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9. Am J Obstet Gynecol. 2016. PMID: 26164695 Review.
Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in women in all strata of society affecting millions of women worldwide. ...
Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in women in all strata of society
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.
Donders G, Sziller IO, Paavonen J, Hay P, de Seta F, Bohbot JM, Kotarski J, Vives JA, Szabo B, Cepuliené R, Mendling W. Donders G, et al. Front Cell Infect Microbiol. 2022 Sep 9;12:934353. doi: 10.3389/fcimb.2022.934353. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36159646 Free PMC article. Review.
Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection, caused by Candida species, which affects women of all ages and ethnic and social background. ...
Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection, caused by Candida species, which
Treatment for recurrent vulvovaginal candidiasis (thrush).
Cooke G, Watson C, Deckx L, Pirotta M, Smith J, van Driel ML. Cooke G, et al. Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD009151. doi: 10.1002/14651858.CD009151.pub2. Cochrane Database Syst Rev. 2022. PMID: 35005777 Free PMC article. Review.
BACKGROUND: Recurrent vulvovaginal candidiasis (RVVC) affects up to 5% of women. ...We also handsearched reference lists of identified trials and contacted authors of identified trials, experts in RVVC, and manufacturers of products for vulvovaginal
BACKGROUND: Recurrent vulvovaginal candidiasis (RVVC) affects up to 5% of women. ...We also handsearched reference list …
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W. Farr A, et al. Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27. Mycoses. 2021. PMID: 33529414 Free PMC article. Review.
Approximately 70-75% of women will have vulvovaginal candidosis (VVC) at least once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and women with acute VVC, Candida albicans is the predominant species. ...Symptoms alone do not allow reliable …
Approximately 70-75% of women will have vulvovaginal candidosis (VVC) at least once in their lifetime. In premenopausal, pregnant, as …
Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis.
Qi W, Li H, Wang C, Li H, Zhang B, Dong M, Fan A, Han C, Xue F. Qi W, et al. Front Cell Infect Microbiol. 2021 Nov 2;11:759795. doi: 10.3389/fcimb.2021.759795. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34796129 Free PMC article. Review.
Moreover, this review summarizes some effective management and laboratory diagnosis of mixed vaginitis to avoid inappropriate therapy, recurrence, and reinfection. It is of high clinical importance to obtain relevant clinical data to improve clinical knowledge about mixed …
Moreover, this review summarizes some effective management and laboratory diagnosis of mixed vaginitis to avoid inappropriate therapy, re
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Sobel JD, Sobel R. Sobel JD, et al. Expert Opin Pharmacother. 2018 Jun;19(9):971-977. doi: 10.1080/14656566.2018.1476490. Epub 2018 Jun 22. Expert Opin Pharmacother. 2018. PMID: 29932786 Review.
INTRODUCTION: Clinicians are increasingly challenged by patients with refractory vulvovaginal candidiasis (VVC) caused by azole-resistant Candida species. ...
INTRODUCTION: Clinicians are increasingly challenged by patients with refractory vulvovaginal candidiasis (VVC) caused by azol …
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Xie HY, et al. Cochrane Database Syst Rev. 2017 Nov 23;11(11):CD010496. doi: 10.1002/14651858.CD010496.pub2. Cochrane Database Syst Rev. 2017. PMID: 29168557 Free PMC article. Review.
BACKGROUND: Vulvovaginal candidiasis (VVC) is estimated to be the second most common form of infection after bacterial vaginosis. ...OBJECTIVES: To assess the effectiveness and safety of probiotics for the treatment of vulvovaginal candidiasis in non-p …
BACKGROUND: Vulvovaginal candidiasis (VVC) is estimated to be the second most common form of infection after bacterial vaginos …
179 results